{"id":250445,"date":"2018-08-06T11:28:02","date_gmt":"2018-08-06T11:28:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=250445"},"modified":"2018-08-06T11:28:02","modified_gmt":"2018-08-06T11:28:02","slug":"antisense-rnai-therapeutics-market-2018-global-analysis-opportunities-and-forecast-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/antisense-rnai-therapeutics-market-2018-global-analysis-opportunities-and-forecast-to-2023_250445.html","title":{"rendered":"Antisense & RNAi Therapeutics Market 2018 Global Analysis, Opportunities And Forecast To 2023"},"content":{"rendered":"
\n
“Antisense & RNAi Therapeutics”<\/div>\n<\/div>\n
Antisense & RNAi Therapeutics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023<\/div>\n

Antisense & RNAi Therapeutics <\/strong>Industry<\/strong><\/a><\/p>\n

Description<\/strong><\/p>\n

Wiseguyreports.Com Adds “Antisense & RNAi Therapeutics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” <\/strong>To Its Research Database<\/p>\n

This report studies the global Antisense & RNAi Therapeutics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Antisense & RNAi Therapeutics market by companies, region, type and end-use industry.<\/p>\n

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene “off”. <\/p>\n

North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market. <\/p>\n

This report focuses on the global top players, covered <\/p>\n

Glaxo Smith Kline <\/strong>
Sanofi Aventis \/ Genzyme <\/strong>
Isis Pharmaceuticals\/ Ionis Pharmaceuticals <\/strong>
Arbutus Biopharma Ltd. <\/strong>
Silence Therapeutics <\/strong>
Bio-Path Holdings Inc. <\/strong>
Calando Pharmaceuticals <\/strong>
ICo Therapeutics <\/strong>
Quark Pharmaceuticals <\/strong>
Rexhan Pharmaceuticals <\/strong>
Biomarin\/Prosensa <\/strong>
Regulus Therapeutics <\/strong>
Rxi Pharmaceuticals <\/strong>
Silenseed <\/strong>
Dicerna Pharmaceuticals <\/strong>
Sirnaomics Inc.<\/strong><\/p>\n

Request for Sample Report @ https:\/\/www.wiseguyreports.com\/sample-request\/3322890-global-antisense-rnai-therapeutics-market-size-status-and-forecast-2025<\/a><\/strong><\/p>\n

Market segment by Regions\/Countries<\/strong>, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India<\/p>\n

Market segment by Type<\/strong>, the product can be split into 
RNA interference 
SiRNA 
MiRNA 
Antisense RNA<\/p>\n

Market segment by Application<\/strong>, split into 
Oncology 
Cardiovascular 
Renal 
Neurodegenerative 
Respiratory 
Genetic 
Infectious Diseases<\/p>\n

For the data information by region<\/strong>, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.<\/p>\n

Key Stakeholders 
Antisense & RNAi Therapeutics Manufacturers 
Antisense & RNAi Therapeutics Distributors\/Traders\/Wholesalers 
Antisense & RNAi Therapeutics Subcomponent Manufacturers 
Industry Association 
Downstream Vendors<\/p>\n

Leave a Query @ https:\/\/www.wiseguyreports.com\/enquiry\/3322890-global-antisense-rnai-therapeutics-market-size-status-and-forecast-2025<\/a><\/strong><\/p>\n

 <\/p>\n

Table of Contents<\/strong><\/p>\n

Global Antisense & RNAi Therapeutics Market Size, Status and Forecast 2025 
1 Industry Overview of Antisense & RNAi Therapeutics 
1.1 Antisense & RNAi Therapeutics Market Overview 
1.1.1 Antisense & RNAi Therapeutics Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Antisense & RNAi Therapeutics Market Size and Analysis by Regions (2013-2018) 
1.2.1 United States 
1.2.2 Europe 
1.2.3 China 
1.2.4 Japan 
1.2.5 Southeast Asia 
1.2.6 India 
1.3 Antisense & RNAi Therapeutics Market by Type 
1.3.1 RNA interference 
1.3.2 SiRNA 
1.3.3 MiRNA 
1.3.4 Antisense RNA 
1.4 Antisense & RNAi Therapeutics Market by End Users\/Application 
1.4.1 Oncology 
1.4.2 Cardiovascular 
1.4.3 Renal 
1.4.4 Neurodegenerative 
1.4.5 Respiratory 
1.4.6 Genetic 
1.4.7 Infectious Diseases<\/p>\n

….<\/p>\n

3 Company (Top Players) Profiles 
3.1 Glaxo Smith Kline 
3.1.1 Company Profile 
3.1.2 Main Business\/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.2 Sanofi Aventis \/ Genzyme 
3.2.1 Company Profile 
3.2.2 Main Business\/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.3 Isis Pharmaceuticals\/ Ionis Pharmaceuticals 
3.3.1 Company Profile 
3.3.2 Main Business\/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.4 Arbutus Biopharma Ltd. 
3.4.1 Company Profile 
3.4.2 Main Business\/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.5 Silence Therapeutics 
3.5.1 Company Profile 
3.5.2 Main Business\/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.6 Bio-Path Holdings Inc. 
3.6.1 Company Profile 
3.6.2 Main Business\/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.7 Calando Pharmaceuticals 
3.7.1 Company Profile 
3.7.2 Main Business\/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.8 ICo Therapeutics 
3.8.1 Company Profile 
3.8.2 Main Business\/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.9 Quark Pharmaceuticals 
3.9.1 Company Profile 
3.9.2 Main Business\/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.10 Rexhan Pharmaceuticals 
3.10.1 Company Profile 
3.10.2 Main Business\/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Antisense & RNAi Therapeutics Revenue (Million USD) (2013-2018) 
3.11 Biomarin\/Prosensa 
3.12 Regulus Therapeutics 
3.13 Rxi Pharmaceuticals 
3.14 Silenseed 
3.15 Dicerna Pharmaceuticals 
3.16 Sirnaomics Inc.<\/p>\n

Buy Now @ https:\/\/www.wiseguyreports.com\/checkout?currency=one_user-USD&report_id=3322890<\/a><\/strong><\/p>\n

Continued…                       <\/strong><\/p>\n

 <\/strong><\/p>\n

Contact Us: <\/strong>Sales@Wiseguyreports.Com<\/strong><\/a> Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)<\/strong><\/p>\n

 <\/strong><\/p>\n

 <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.wiseguyreports.com\/sample-request\/3322890-global-antisense-rnai-therapeutics-market-size-status-and-forecast-2025<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Antisense & RNAi Therapeutics” Antisense & RNAi Therapeutics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Antisense & RNAi Therapeutics Industry Description Wiseguyreports.Com Adds “Antisense & RNAi Therapeutics -Market Demand, Growth, Opportunities and Analysis Of Top Key … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-250445","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/250445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=250445"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/250445\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=250445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=250445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=250445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}